HomeTOP STORIESModerna shares drop after FDA refuses to file for mRNA-1010 influenza vaccine Moderna shares drop after FDA refuses to file for mRNA-1010 influenza vaccine By rogerjudd February 11, 2026 FacebookTwitterPinterestWhatsApp Post Content Previous articleCanada launched major gun reforms in 2020 after its deadliest mass shooting.Next articleBlackLine targets 9–9.6% revenue growth for 2026 as platform adoption accelerates latest articles Here are the worst performing real estate services stocks as AI disruptions sink group Manulife Q4 earnings beat consensus, ending 2025 on a strong note Canada Mass Shooting: What to Know About the Home and School Shootings in Tumbler Ridge, B.C. Military’s Use of Anti-Drone Technology Said to Cause El Paso Airspace Closure Corecivic Non-GAAP EPS of $0.27 beats by $0.06, revenue of $604M beats by $18.88M Stag Industrial Q4 earnings, revenue beat amid healthy leasing activity explore more Here are the worst performing real estate services stocks as AI disruptions sink group Manulife Q4 earnings beat consensus, ending 2025 on a strong note Canada Mass Shooting: What to Know About the Home and School Shootings in Tumbler Ridge, B.C. Military’s Use of Anti-Drone Technology Said to Cause El Paso Airspace Closure Corecivic Non-GAAP EPS of $0.27 beats by $0.06, revenue of $604M beats by $18.88M Stag Industrial Q4 earnings, revenue beat amid healthy leasing activity
